Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

Abstract: As we transition from the 5G epoch, a new horizon beckons with the advent of 6G, seeking a profound fusion with novel communication paradigms and emerging technological trends, bringing once ...

Routine use of the Impella CP microaxial flow pump did not improve outcomes and may have contributed to deaths among patients undergoing high-risk percutaneous coronary intervention (PCI), according ...

In a whistleblower lawsuit, a prominent cardiologist says he was fired from the University of Pittsburgh Medical Center (UPMC) after reporting racist text messages exchanged between colleagues and a ...

Abiomed has issued two recalls affecting Impella heart pump systems and related components due to device performance issues and patient safety risks. The first action involves a correction to Impella ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Add Yahoo as a preferred source to see more of our stories on Google. Johnson & Johnson's Impella CP heart pump in an illustration of the heart. Johnson & Johnson’s Impella heart pump failed to lower ...

J&J’s Impella pumps, acquired in the $16.6 billion purchase of Abiomed in 2022, have been a strong growth driver for the company’s cardiovascular business, contributing $1.75 billion to sales in 2025.

Two separate randomized trials of Johnson & Johnson’s miniaturized Impella heart pumps failed to illustrate the devices’ benefits, spanning specific cases in patients with blockages in their coronary ...